ACE and hypertensive disorder: Moreover, among 1,128 hospitalized COVID-19 patients with hypertension from Hubei, China, the inpatient use of ACE inhibitors/ARB was reported to be associated with lower risk of all-cause mortality compared with ACE inhibitors/ARB non-users (19).